By slicing and dicing the data, the study confirms MITRA-FR as an outlier and emphasizes the need for careful patient selection.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results